HRP20120416T1 - Postupci pripreme i uporabe smjesa kelata feri pirofosfat citrata - Google Patents

Postupci pripreme i uporabe smjesa kelata feri pirofosfat citrata Download PDF

Info

Publication number
HRP20120416T1
HRP20120416T1 HRP20120416AT HRP20120416T HRP20120416T1 HR P20120416 T1 HRP20120416 T1 HR P20120416T1 HR P20120416A T HRP20120416A T HR P20120416AT HR P20120416 T HRP20120416 T HR P20120416T HR P20120416 T1 HRP20120416 T1 HR P20120416T1
Authority
HR
Croatia
Prior art keywords
ferric
pyrophosphate
citrate
source
amount
Prior art date
Application number
HRP20120416AT
Other languages
English (en)
Croatian (hr)
Inventor
William@S@@McCall@jr
Original Assignee
Rockwell@Medical@Technologies@Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockwell@Medical@Technologies@Inc filed Critical Rockwell@Medical@Technologies@Inc
Publication of HRP20120416T1 publication Critical patent/HRP20120416T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HRP20120416AT 2007-07-20 2012-05-15 Postupci pripreme i uporabe smjesa kelata feri pirofosfat citrata HRP20120416T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96132707P 2007-07-20 2007-07-20
US12/138,018 US7816404B2 (en) 2007-07-20 2008-06-12 Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions

Publications (1)

Publication Number Publication Date
HRP20120416T1 true HRP20120416T1 (hr) 2012-07-31

Family

ID=40019183

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20120416AT HRP20120416T1 (hr) 2007-07-20 2012-05-15 Postupci pripreme i uporabe smjesa kelata feri pirofosfat citrata

Country Status (11)

Country Link
US (1) US7816404B2 (de)
EP (1) EP2016940B1 (de)
JP (1) JP5489196B2 (de)
AT (1) ATE554754T1 (de)
CY (1) CY1113903T1 (de)
DK (1) DK2016940T3 (de)
ES (1) ES2383713T3 (de)
HR (1) HRP20120416T1 (de)
PL (1) PL2016940T3 (de)
PT (1) PT2016940E (de)
SI (1) SI2016940T1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090124572A1 (en) * 2007-11-09 2009-05-14 Deanna Jean Nelson Iron-containing nutritional supplement
WO2009158032A1 (en) * 2008-06-25 2009-12-30 Fe2, Inc. Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
DK2346470T3 (da) * 2008-09-29 2013-03-04 Vifor Int Ag Beholder og fremgangsmåde til opbevaring og levering af en væske og et væskeformet medicinsk præparat
US8190252B2 (en) 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US9008765B2 (en) 2009-02-12 2015-04-14 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US8348922B2 (en) * 2009-02-12 2013-01-08 Incube Labs, Llc Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US8821945B2 (en) 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
US8417330B2 (en) * 2009-06-26 2013-04-09 Incube Labs, Llc Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use
US8178709B2 (en) * 2009-07-21 2012-05-15 Biolink Life Sciences, Inc. Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof
WO2011044175A2 (en) 2009-10-06 2011-04-14 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
US8986279B2 (en) 2010-02-10 2015-03-24 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
EP2497380A1 (de) * 2011-03-10 2012-09-12 DSM IP Assets B.V. Verfahren für die Eisenergänzung in Getränken
CN106955415B (zh) 2011-03-24 2019-06-18 因卡伯实验室有限责任公司 用于治疗剂的两阶段经皮离子电渗递送的系统及方法
RU2472500C1 (ru) * 2012-05-05 2013-01-20 Илья Николаевич Медведев Способ нормализации активности антитромбина iii в крови у новорожденных телят с железодефицитной анемией
PH12014502336B1 (en) * 2012-05-08 2022-07-06 Dsm Ip Assets Bv Iron supplementation of rice kernels
BR112015018549A8 (pt) * 2013-02-01 2018-01-30 Charak Llc métodos de tratamento de deficiência de ferro
CN105517454B (zh) * 2013-08-28 2018-07-03 帝斯曼知识产权资产管理有限公司 肉汤浓缩物的铁补充
KR20160091918A (ko) * 2013-11-05 2016-08-03 락웰 메디컬, 인코포레이티드 저반응성 환자에서 에리스로포이에틴 자극제의 용량을 감소시키는 방법
EP3157516A4 (de) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmazeutische zusammensetzungen mit eisencitrat und verfahren zur herstellung davon
WO2016166920A1 (ja) * 2015-04-13 2016-10-20 富田製薬株式会社 ピロリン酸第二鉄含有粉末及びその製造方法
JP5963185B1 (ja) * 2015-04-13 2016-08-03 富田製薬株式会社 ピロリン酸第二鉄含有粉末及びその製造方法
JP7055738B2 (ja) * 2015-09-04 2022-04-18 ロックウェル メディカル，インコーポレイテッド 固体の可溶性ピロリン酸第二鉄製剤、キット、およびそれを使用する方法
US10456418B2 (en) * 2015-10-05 2019-10-29 Navinta, Llc Preparation of pharmaceutical dosage forms containing iron (III) salts
JP2019501184A (ja) 2016-01-06 2019-01-17 ロックウェル メディカル，インコーポレイテッド 鉄化合物及びシトレート化合物を用いる併用療法
CN106977552B (zh) * 2016-01-19 2019-11-05 山东诚创医药技术开发有限公司 枸橼酸焦磷酸铁混配络合物的制备方法
JP6887598B2 (ja) * 2016-07-21 2021-06-16 富田製薬株式会社 鉄含有飲食品
CN106619494A (zh) * 2016-10-10 2017-05-10 泰州海达医药科技有限公司 枸橼酸焦磷酸铁溶液及其制备方法
US11785974B2 (en) 2017-03-31 2023-10-17 Abbott Laboratories Liquid nutritional compositions containing oxidizable fish oil, rosmarinic acid, and ferric iron
EP3778868B1 (de) 2019-08-16 2022-01-26 UGA Biopharma GmbH Zellkulturmedium zur kultivierung von zellen, verfahren zum kultivieren von zellen und verfahren zur expression von mindestens einem rekombinanten protein in einer zellkultur
CN112159434A (zh) * 2020-09-23 2021-01-01 北京沣瑞医药科技有限公司 枸橼酸焦磷酸铁配合物的制备方法
MY210100A (en) * 2020-09-29 2025-08-27 Lg Bionano Llc Methods of preparing iron complexes
CN112516163A (zh) * 2020-12-21 2021-03-19 西安医学院 一种难溶性三价铁纳米脂质体复合物及其制备方法
CA3280511A1 (en) 2024-07-18 2026-03-01 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases and iron supplementation in neurodevelopmental or psychiatric disorder

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE579299A (de) 1958-06-04
US3275514A (en) 1960-04-12 1966-09-27 Paul D Saltman Process for introduction of metals into the mammalian system
US3259500A (en) 1961-10-11 1966-07-05 Kentucky Res Foundation Method for inhibiting anemia in young pigs by feeding the sow an iron agent
US3367834A (en) 1965-05-04 1968-02-06 Dexter Martin Method and compositions for enhancing the utilization of iron by mammals
AT279048B (de) * 1967-07-04 1970-02-25 Pharmazeutische Fabrik Montavit Gmbh Verfahren zur Herstellung neuer, löslicher und stabiler organischer Eisen(III)-Komplexverbindungen und Injektionslösungen davon
US3686397A (en) 1970-05-18 1972-08-22 Mueller Arthur Parenteral iron preparations
SE359447B (de) 1971-10-06 1973-09-03 Astra Laekemedel Ab
US4167564A (en) 1974-09-23 1979-09-11 Albion Laboratories, Inc. Biological assimilation of metals
US4058621A (en) 1975-02-24 1977-11-15 Peter, Strong & Company, Inc. Iron complexes and foodstuffs containing them
JPS5626709A (en) * 1979-08-04 1981-03-14 Nichia Kagaku Kogyo Kk Manufacture of water soluble iron salt
EP0107458B1 (de) 1982-10-22 1987-07-29 National Research Development Corporation Pharmazeutische Zusammensetzungen
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8713169D0 (en) 1987-06-05 1987-07-08 Peters T J Uptake of iron by body
CO4410161A1 (es) 1994-02-28 1997-01-09 Kellog Co Producto de cereal listo para comer fortificado con complejo de edta ferrico y metodo para producirlo
DE69734781T2 (de) * 1996-12-31 2006-07-20 Gupta, Ajay, Cerritos Verfahren und pharmazeutische zusammensetzung zum zuführen von eisen bei hämodialyse-und peritonealdialysepatienten
AU6605100A (en) 1999-06-30 2001-01-31 Ajay Gupta Method and pharmaceutical composition for parenteral administration of iron
US20030190355A1 (en) 2002-04-05 2003-10-09 Hermelin Marc S. Modified release minerals
TWI335218B (en) * 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US20060134227A1 (en) 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
BRPI0620425B8 (pt) * 2005-12-23 2021-06-22 Gupta Ajay composição para nutrição parenteral, método para preparar a mesma, uso, e, kit

Also Published As

Publication number Publication date
US7816404B2 (en) 2010-10-19
US20090023686A1 (en) 2009-01-22
EP2016940B1 (de) 2012-04-25
ES2383713T3 (es) 2012-06-25
PT2016940E (pt) 2012-07-12
CY1113903T1 (el) 2016-07-27
JP5489196B2 (ja) 2014-05-14
DK2016940T3 (da) 2012-06-18
EP2016940A1 (de) 2009-01-21
JP2009108027A (ja) 2009-05-21
SI2016940T1 (sl) 2012-07-31
ATE554754T1 (de) 2012-05-15
PL2016940T3 (pl) 2012-09-28

Similar Documents

Publication Publication Date Title
HRP20120416T1 (hr) Postupci pripreme i uporabe smjesa kelata feri pirofosfat citrata
McCann The solubility of fluorapatite and its relationship to that of calcium fluoride
Cincinelli et al. Design, modeling, synthesis and biological activity evaluation of camptothecin-linked platinum anticancer agents
Dong et al. Molecular dynamics simulations of the binging affinity of 1-hydroxyethane-1, 1-diphosphonic acid (HEDP) with nano-hydroxyapatite and the uptake of Cu2+ by HEDP-HAP hybrid systems
JP2014527905A5 (ja) 水流中の有機リン酸類を減少させる方法
CN105112900B (zh) 用于循环冷却水系统的无磷预膜剂及其制备和使用方法
JP2015110646A5 (de)
JPH01258693A (ja) オキサアルカンポリホスホン酸ならびにそれを含む限界剤および錯化組成物
Cawthray et al. In vivo study and thermodynamic investigation of two lanthanum complexes, La (dpp) 3 and La (XT), for the treatment of bone resorption disorders
Brown et al. Heteronuclear NMR studies of cobalamins. 2. Carbon-13 and phosphorus-31 NMR studies of [13C] cyanocobalamin
BR122019000367B1 (pt) Processo para a inibição ou eliminação da formação de incrustações durante a produção de ácido fosfórico em um processo úmido
CN107098832A (zh) 一种和厚朴酚衍生物及其制备方法与应用
US20070088161A1 (en) Novel chelated bisphosphonates for use as pharmaceutical agents
CN104562031B (zh) 一种预膜用组合物及预膜方法
WO2012099304A1 (ko) 중성에서 안정한 고농도 인산칼슘 수용액의 제조방법
CA2638081A1 (en) Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
Gumienna-Kontecka et al. Coordination abilities of substituted β-aminophosphonates towards Cu2+ and Zn2+ ions
US10456418B2 (en) Preparation of pharmaceutical dosage forms containing iron (III) salts
CN111358991B (zh) 一种鞋袜除臭抗菌组合物及其制备方法
CN103450202B (zh) L-5-甲基四氢叶酸与有机碱加成盐的方法
CN100362021C (zh) 山药多糖-铁复合物及其制备工艺
CN102677034A (zh) 一种中温低渣锌系磷化液
JP5591263B2 (ja) ミネラル添加と酸処理を用いてメチオニンの溶解度を増加させる方法
CN101775032A (zh) 氯硝柳胺磷酸酯、其药学上可接受的盐及其应用
CN106519071A (zh) 一种抗肿瘤药物6‑羟基亚硒酸酯化壳聚糖铜的合成方法